Frank BurrellScientific Storytelling
Brenda SnowAuthentic Patient Voice
David LinetskyPoint-of-Care Marketing
Bud BilanichSuccess Coach
Matthew DurhamOmnidynamic Marketing
Amy GilesIncreasing Engagement
Pat PurcellMeeting Engagement
Paul TheisenPatient Acquisition
Stacey GandlerBrand Nourishment
Liz KaneImpactful Strategy
Suma Ramadas, PhDMedical Affairs
Matt TurnerPatient Affordability
Daniel SontupeMarket Access
Joey CohenMedication Adherence
SALT LAKE CITY, Nov. 16, 2015 (GLOBE NEWSWIRE) -- Myriad RBM, a wholly-owned subsidiary ...
Lenabasum is a first-in-class novel, synthetic oral cannabinoid designed to treat rare, serious autoimmune ...
- OncoDNA to support patient enrolment for Kura Oncology’s Phase II trial of tipifarnib- ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email